BroadEye: An Ophthalmology Podcast

BroadEye: An Ophthalmology Podcast Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from BroadEye: An Ophthalmology Podcast, Podcast, Hill, NH.

Authentic conversations about the knowledge gaps in ophthalmology and eye care, With guests hailing from ophthalmology and optometry clinics, vision research labs, industry, private companies, and the low vision community.

In this episode of the BroadEYE Podcast, hosts Shawn Maloney and Dr. Bruno Fernandes dive into a fascinating discussion ...
04/08/2025

In this episode of the BroadEYE Podcast, hosts Shawn Maloney and Dr. Bruno Fernandes dive into a fascinating discussion with Dr. Peter Campochiaro, a clinician-scientist at Johns Hopkins’ Wilmer Eye Institute, about the potential of N-acetylcysteine (NAC) as a treatment for retinitis pigmentosa (RP).

Dr. Campochiaro shares how his research journey began with unexpected findings in mouse models, revealing how excess oxygen in the retina—caused by the loss of rod photoreceptors in RP—leads to oxidative stress that damages surviving cone cells. This discovery paved the way for the NAC Attack clinical trial, a phase 3 study exploring whether NAC, a potent antioxidant, can slow cone degeneration and preserve vision in RP patients.

The conversation covers the science behind NAC, its safety profile, and why it was chosen over other antioxidants like glutathione or CoQ10. Shawn, who lives with late-stage RP, brings a personal perspective, while Bruno, an ophthalmologist, digs into the broader implications for retinal diseases. Dr. Campochiaro also addresses practical challenges, like NAC’s over-the-counter availability versus its regulated use, and cautions against self-medication without medical supervision.

The episode offers hope for RP patients while emphasizing the importance of awaiting trial results, expected in a couple of years, to confirm NAC’s efficacy and long-term safety.

In this episode of the BroadEYE Podcast, hosts Shawn Maloney and Dr. Bruno Fernandes dive into a fascinating discussion with Dr. Peter Campochiaro, a clinician-scientist at Johns Hopkins’ Wilmer Eye Institute, about the potential of N-acetylcysteine (NAC) as a treatment … NAC Attack Clinical Tri...

In this episode our guest is Dagmar Venclik Jamieson, a mentor and life coach at CNIB. We discuss the challenges in ever...
06/29/2022

In this episode our guest is Dagmar Venclik Jamieson, a mentor and life coach at CNIB. We discuss the challenges in everyday life as a visually impaired person, how that affects our social skills, are there any professional limitations and how does Dagmar cope with all those challenges.

Spotify: https://spoti.fi/3bqbAmn
Apple podcast: https://apple.co/3yrKe8G
Google podcast: https://bit.ly/3QWPF6I

In this episode our guest is Dagmar Jamieson, a mentor and life coach at CNIB. We discuss the challenges in everyday life as a visually impaired person, how that affects our social skills, are there any professional limitations and how does Dagmar cope with all those challenges.

Ariel Cao is the president/CEO and co-founder of Injectsense. We talked about the current challenges in the management o...
06/23/2022

Ariel Cao is the president/CEO and co-founder of Injectsense. We talked about the current challenges in the management of patients with glaucoma, still one of the major causes of blindness worldwide. Cao and his team developed an implantable intraocular device that can continuously monitor intraocular pressure. By providing accurate, clinically actionable information, physicians will be able to individualize therapeutic interventions for each patient, properly assess the effectiveness of glaucoma therapy, and ultimately avoid blindness.

Links to the podcast:

http://broadeye.org/cao/

Spotify: https://spoti.fi/3OlFEhG
Apple podcast: https://apple.co/39PzPtW
Google podcast: https://bit.ly/3QHOTub

Dr. Ariel Cao is the president/CEO and co-founder of Injectsense. We talked about the current challenges in the management of patients with glaucoma, still one of the major causes of blindness worldwide. Dr. Cao and his team developed an implantable intraocular device that can continuously monitor i...

In this episode, we review differences in regulatory requirements for branded and generic therapeutic agents, and how th...
06/09/2022

In this episode, we review differences in regulatory requirements for branded and generic therapeutic agents, and how these differences can manifest in eye care. Dr. Andrew Meagher sheds light on the subject using IOP-lowering glaucoma drops as an example.

Drawing on his experience in the clinic and keen attention to scientific detail, Dr. Meagher shares knowledge as Associate Professor at the Salus University, School of Optometry.

Spotify: https://spoti.fi/3NFOSF7
Apple podcasts: https://apple.co/3mAfA66
Google podcasts: https://bit.ly/3Hbmlok

The Eye Institute American Academy of Optometry

In this episode, we review differences in regulatory requirements for branded and generic therapeutic agents, and how these differences can manifest in eye care. Dr. Andrew Meagher sheds light on the subject using IOP-lowering glaucoma drops as an example. Drawing on his experience in the clinic and...

In this episode, we had the chance to talk with Dr. Farris about his charitable work in eye care both in the United Stat...
04/27/2022

In this episode, we had the chance to talk with Dr. Farris about his charitable work in eye care both in the United States and internationally. For the past 20 years, he has led a team annually from Dean McGee Eye Institute to develop academic exchange and work with the local residency-training programs in China. He has done the same in Africa for the past 11 years.

Dr. Farris is the 2021 recipient of the Outstanding Humanitarian Service Award by the American Academy of Ophthalmology and Professor Emeritus of Ophthalmology at The University of Oklahoma and Dean McGee Eye Institute.

Spotify: https://spoti.fi/3xWhx3E
Google Podcasts: https://bit.ly/3rVwlMk
Apple Podcasts: https://apple.co/3y26cz9

Instilling the call for humanitarian service – Dr. Bradley Farris By BroadEye Posted on April 27, 2022 Posted in Uncategorized No Comments In this episode, we had the chance to talk with Dr. Farris about his charitable work in eye care both in the United States and internationally. For the past 20...

Dr. Duker is an accomplished ophthalmologist, that is now the Chief Operating Officer of EyePoint Pharmaceuticals, a bio...
04/21/2022

Dr. Duker is an accomplished ophthalmologist, that is now the Chief Operating Officer of EyePoint Pharmaceuticals, a biotech company that develops sustained-release medications to treat serious ocular disorders. We talked about his career path and what motivated him to move from a clinical to an executive position. For the 21 years before he took the COO position at EyePoint, Dr. Duker was the Director of the New England Eye Center (NEEC) and Professor and Chair of the Department of Ophthalmology at Tufts Medical Center, Tufts University School of Medicine in Boston, Massachusetts. Dr. Duker received his medical degree from Jefferson Medical College. He completed a residency and fellowship in vitreoretinal diseases and ocular oncology at the Wills Eye Hospital.

Spotify: https://spoti.fi/3K4UZ3p
Google Podcasts: https://bit.ly/3k1xI7O
Apple Podcasts: https://apple.co/3v2CRCG

American Academy of Ophthalmology American Society of Retina Specialists Surgisite Boston Sesen Bio

Dr. Duker is an accomplished ophthalmologist, that is now the Chief Operating Officer of EyePoint Pharma, a biotech company that develops sustained-release medications to treat serious ocular disorders. We talked about his career path and what motivated him to move from a clinical to an executive po...

What might come as a surprise to most people is that the visually impaired can draw!Dr. Kennedy is a Professor of Psycho...
04/13/2022

What might come as a surprise to most people is that the visually impaired can draw!

Dr. Kennedy is a Professor of Psychology at the University of Toronto and is especially interested in the theory of pictures drawn by people who are blind. The key idea is that lines in outline drawings mean the same thing to the sighted and people who are blind – edges of surfaces, such as profiles of people and corners of cubes. These shapes are understood via touch as well as vision. We also talked about how drawing kits are now made available free to all children who are blind in the US and his book on the topic: Drawing and the Blind: Pictures to Touch.

Spotify: https://spoti.fi/3uDTAMH
Google Podcasts: https://bit.ly/3JLCv7W
Apple Podcasts: https://apple.co/3vfKkxp

Harvard University

What might come as a surprise to most people is that the visually impaired can draw! Dr. Kennedy is a Professor of Psychology at the University of Toronto and is especially interested in the theory of pictures drawn by people who are blind. The key idea is that lines in outline drawings mean the sam...

In this episode, we learned how Orbis International is much more than a Flying Hospital. Using the latest technologies s...
04/06/2022

In this episode, we learned how Orbis International is much more than a Flying Hospital. Using the latest technologies such as AI and telemedicine, Dr. Hunter Cherwek is leading a global initiative to train ophthalmologists and help eliminate avoidable blindness in low-resource communities.

Spotify: https://spoti.fi/3j8dZmn
Google Podcasts: https://bit.ly/3DKVSfO
Apple Podcasts: https://apple.co/3NQNLTs

Emory University Cybersight Alcon

In this episode, we learned how Orbis International is much more than a flying hospital. Using the latest technologies such as AI and telemedicine, Dr. Hunter Cherwek is leading a global initiative to train ophthalmologists and help eliminate avoidable blindness in low-resource communities.

Christian is the Head of Digital Therapeutics and Director of Business Development at Twenty Twenty Therapeutics, a join...
03/28/2022

Christian is the Head of Digital Therapeutics and Director of Business Development at Twenty Twenty Therapeutics, a joint venture between Verily Life Sciences, an Alphabet company, and Santen, a leading Japanese pharmaceutical company. We talked about the company’s vision to eliminate preventable blindness with technology that empowers patients to care for their own vision between doctors’ visits.

Spotify: https://spoti.fi/36BfFlJ
Google Podcasts: https://bit.ly/3tKmDO0
Apple Podcasts: https://apple.co/36YPTI8

Christian is the Head of Digital Therapeutics and Director of Business Development at Twenty Twenty Therapeutics, a joint venture between Verily Life Sciences, an Alphabet company, and Santen, a leading Japanese pharmaceutical company. We talked about the company’s vision to eliminate preventable ...

Dr. Gail Seigel is an accomplished researcher, helping to develop more efficient ways to treat retinoblastoma. We also h...
03/20/2022

Dr. Gail Seigel is an accomplished researcher, helping to develop more efficient ways to treat retinoblastoma. We also had the chance to chat about her role in the Rochester NY March For Science, a global movement that aims to promote science for the common good and equitable access to scientific education and opportunities.

Spotify: https://spoti.fi/3IocfzK
Google Podcasts: https://bit.ly/3wmYnn0
Apple Podcasts: https://apple.co/3ql6jRM

State University of New York at Buffalo SUNY Buffalo State College Research to Prevent Blindness (RPB) Fight for Sight ARVO

Dr. Seigel is an accomplished researcher, helping to develop more efficient ways to treat retinoblastoma. We also had the chance to chat about her role in the Rochester NY March for Science, a global movement that has one of its goals to promote science for the common good and equitable access to sc...

In this episode, Dr. Bill Stell gives a comprehensive overview of the most promising clinical research and potential tre...
03/08/2022

In this episode, Dr. Bill Stell gives a comprehensive overview of the most promising clinical research and potential treatments for inherited retinal diseases, including Retinitis Pigmentosa. Dr. Stell further explores avenues for retired researchers and clinicians to continue helping patients and mentoring young professionals.

Spotify: https://spoti.fi/3ITeSKT
Google Podcasts: https://bit.ly/3vNUsPA
Apple Podcasts: https://apple.co/3CohFJz

Cu***ng School of Medicine Jules Stein Eye Institute The Juliette RP Vision Foundation, Fighting Blindness Canada National Eye Institute National Organization for Rare Disorders, Retina International

In this episode, Dr. Bill Stell gives a comprehensive overview of the most promising clinical research and potential treatments for inherited retinal diseases, including Retinitis Pigmentosa. Dr. Stell further explores avenues for retired researchers and clinicians to continue helping patients and m...

In this episode, Dr. Dennis Levi provides an in-depth overview of the causes and treatment options for patients with  . ...
03/01/2022

In this episode, Dr. Dennis Levi provides an in-depth overview of the causes and treatment options for patients with . Dr. Levi highlights how virtual reality and perceptual learning are becoming increasingly important in optimizing stereovision.

Spotify: https://spoti.fi/3IyHSY1
Google Podcasts: https://bit.ly/3Iy6IHr
Apple Podcasts: https://apple.co/35Gh9Kt

UC Berkeley UC Berkeley School of Optometry Herbert Wertheim School of Optometry & Vision Science Helen Wills Neuroscience Institute National Eye Institute Optical Society of America Optical Society of America American Academy of Optometry Guinness World Records Optica

In this episode, Dr. Dennis Levi provides an in-depth overview of the causes and treatment options for patients with Amblyopia. Dr. Levi highlights how virtual reality and perceptual learning are becoming increasingly important in optimizing stereovision.

In this episode, Dr. Mark Pennesi provides an overview of inherited retinal dystrophies and how CRISPR is being used to ...
02/22/2022

In this episode, Dr. Mark Pennesi provides an overview of inherited retinal dystrophies and how CRISPR is being used to edit DNA in the eyes of patients. Dr. Pennesi further shares recent research findings from a clinical trial using CRISPR to treat patients with Leber Congenital Amaurosis.

Spotify: https://spoti.fi/3p9RGjB
Google Podcasts: https://bit.ly/36qjREl
Apple Podcasts: https://apple.co/3H472fG

Oregon Health & Science University (OHSU) OHSU Casey Eye Institute Research to Prevent Blindness (RPB) Foundation Fighting Blindness

In this episode, Dr. Mark Pennesi provides an overview of inherited retinal dystrophies and how CRISPR is being used to edit DNA in the eyes of patients. Dr. Pennesi further shares recent research findings from a clinical trial using CRISPR to treat patients with Leber Congenital Amaurosis.

Our very own host Shawn Maloney featured at the John Molson School of Business page!
02/20/2022

Our very own host Shawn Maloney featured at the John Molson School of Business page!

John Molson grad Shawn Maloney’s new venture combines science and entrepreneurship

In this episode, Anthony Ferraro shares the story of his journey from being diagnosed with Leber Congenital Amaurosis — ...
02/15/2022

In this episode, Anthony Ferraro shares the story of his journey from being diagnosed with Leber Congenital Amaurosis — a rare and blinding eye disease — to training for the 2024 Paralympic Games. In recent years, Anthony has gained an incredible following on social media as an inspiring athlete, amateur musician, and overall beacon of positivity.

Spotify: https://spoti.fi/34K6luX
Google Podcasts: https://bit.ly/3GR9dmE
Apple Podcasts: https://apple.co/3JxDwAq

In this episode, Anthony Ferraro shares the story of his journey from being diagnosed with Leber Congenital Amaurosis — a rare and blinding eye disease — to training for the 2024 Paralympic Games. In recent years, Anthony has gained an incredible following on social media as an inspiring athlete...

02/09/2022

The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. The podcasts are hosted by Ben Shaberman, senior director scientific outreach, and often include conversations with guests from the resea...

In this episode, Dr. Jacque Duncan provides an overview of how The Foundation Fighting Blindness is funding critical res...
02/08/2022

In this episode, Dr. Jacque Duncan provides an overview of how The Foundation Fighting Blindness is funding critical research that could impact millions of patients with inherited and degenerative retinal diseases. Dr. Duncan further describes her research focus which aims to preserve vision and stimulate visual function.

Spotify: https://spoti.fi/3GBkYNS
Google Podcasts: https://bit.ly/3ryfWO4
Apple Podcasts: https://apple.co/34CAWKt

University of California University of Pennsylvania National Eye Institute

In this episode, Dr. Jacque Duncan provides an overview of how The Foundation Fighting Blindness is funding critical research that could impact millions of patients with inherited and degenerative retinal diseases. Dr. Duncan further describes her research focus which aims to preserve vision and sti...

In this episode, Ophthalmologist Dr. Allen Roth gives an overview of corneal disease management and how these practices ...
02/01/2022

In this episode, Ophthalmologist Dr. Allen Roth gives an overview of corneal disease management and how these practices have changed in recent years. Dr. Roth also discusses his role as President of Cleveland Eye Bank Foundation, highlighting cutting-edge research supported by the Foundation and explaining how the community can get involved.

Spotify: https://spoti.fi/3rgAHNY
Google Podcasts: https://bit.ly/3IS3Rcj
Apple Podcasts: https://apple.co/3GkI2QO

Cleveland Clinic Cole Eye Institute - Cleveland Clinic Case Western Reserve University 2nd Annual Virtual Vision Research Symposium

Native to Northeast Ohio, Allen Roth, M.D., FACS, returned to Cleveland in 1988 following his fellowship at Tulane University. After 12 years of private practice, Dr. Roth joined Cleveland Clinic's Eye Institute in January 1999, which soon after became the Cole Eye Institute. He has been an ophthalm...

Address

Hill, NH

Alerts

Be the first to know and let us send you an email when BroadEye: An Ophthalmology Podcast posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to BroadEye: An Ophthalmology Podcast:

Share

Category